SCHEMBL2771917

SCHEMBL2771917

S=[C]Nc1cc(Cl)cc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2771689 0.80 NOS3 (0.35) —
SCHEMBL18103976 0.71 ALDH1A1 (0.42) —
SCHEMBL21922822 0.71 NOS3 (0.41) —
SCHEMBL2770492 0.71 ALDH1A1 (0.44) —
SCHEMBL2771920 0.71 — —
SCHEMBL19687284 0.68 HSP90AA1 (0.32) —
SCHEMBL190461 0.68 — —
SCHEMBL12127970 0.67 TRPM8 (0.39) —
SCHEMBL26894175 0.67 LMNA (0.39) —
SCHEMBL16965029 0.65 S1PR2 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103249732-A Bacteria topoisomerase II inhibiting 2-thylcarbamoylamino-1, 3-benzothiazol-5-yls BIOTA EUROPE LTD 2013-08-14 — — CN disclosed
EP-2181112-A1 TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE AS ASK INHIBITORS Merck Serono S.A. (CH) 2010-05-05 — — EP disclosed
WO-2009027283-A1 TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE AS ASK INHIBITORS MERCK SERONO S.A. (CH) 2009-03-05 — — WO disclosed
Send feedback